Sort   by:  
 Page size 
TranscriptomicsEffect of c-MET inhibitor SU11274 upon sensitive (RPMI8226) or multi-resistant (RPMI8226/R5) Multiple Myeloma cell lines
The c-MET signaling axis is increasingly implicated in tumorigenesis and chemioresistance. In this study, we investigated gene expression modifications induced by SU11274 (Selleck Chemicals, Boston, USA), a novel selective c-MET inhibitor, in a pair of isogenic multiple myeloma (MM) cell lines eithe...
ORGANISM(S): Homo sapiens 
2012-05-25 | GSE38204 | GEO
GenomicsRNAseq of primary colorectal cancer cell lines.
RNAseq of primary colorectal cancer cell lines.
PRJNA680585 | ENA
TranscriptomicsEffect of c-MET inhibitor SU11274 upon sensitive (RPMI8226) or multi-resistant (RPMI8226/R5) Multiple Myeloma cell lines
The c-MET signaling axis is increasingly implicated in tumorigenesis and chemioresistance. In this study, we investigated gene expression modifications induced by SU11274 (Selleck Chemicals, Boston, USA), a novel selective c-MET inhibitor, in a pair of isogenic multiple myeloma (MM) cell lines eithe...
ORGANISM(S): Homo sapiens 
2012-05-24 | E-GEOD-38204 | biostudies-arrayexpress
ProteomicsLipid metabolism reprogramming and Trastuzumab resistance in Breast cancer cell lines overexpressing the ERBB2 membrane receptor.
ERBB2 overexpression is associated with aggressive breast cancer (BCa) disease. The introduction in the clinic of Trastuzumab (Tz) targeting this receptor has considerably improved patient outcomes. However, de novo or acquired resistance to Tz occurs and negatively impacts prognosis. Many molecula...
ORGANISM(S): Homo sapiens (Human) 
2023-05-23 | PXD037657 | Pride
Human Cancer Chemioresistance Breast Cell culture 
GenomicsHomo sapiens
Effect of c-MET inhibitor SU11274 upon sensitive (RPMI8226) or multi-resistant (RPMI8226/R5) Multiple Myeloma cell lines
PRJNA167513 | ENA
Sort   by:  
 Page size